Comerica Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.24M | Sell |
6,197
-7,829
| -56% | -$1.42M | ﹤0.01% | 1397 |
|
|
2025
Q3 | $2.19M | Sell |
14,026
-226
| -2% | -$35.9K | 0.01% | 1115 |
|
|
2025
Q2 | $2.16M | Buy |
14,252
+1,524
| +12% | +$203K | 0.01% | 1091 |
|
|
2025
Q1 | $1.92M | Sell |
12,728
-518
| -4% | -$86.8K | 0.01% | 1135 |
|
|
2024
Q4 | $2.45M | Sell |
13,246
-3,230
| -20% | -$622K | 0.01% | 1041 |
|
|
2024
Q3 | $3.25M | Sell |
16,476
-671
| -4% | -$139K | 0.01% | 911 |
|
|
2024
Q2 | $3.54M | Sell |
17,147
-367
| -2% | -$83.2K | 0.01% | 861 |
|
|
2024
Q1 | $4.75M | Buy |
17,514
+927
| +6% | +$221K | 0.02% | 737 |
|
|
2023
Q4 | $3.92M | Sell |
16,587
-982
| -6% | -$193K | 0.02% | 813 |
|
|
2023
Q3 | $3.44M | Sell |
17,569
-6,008
| -25% | -$1.23M | 0.02% | 801 |
|
|
2023
Q2 | $24 | Buy |
+23,577
| New | +$4.69M | ﹤0.01% | 266 |
|
|
2022
Q4 | $1.54M | Sell |
6,526
-2,000
| -23% | -$437K | 0.01% | 1223 |
|
|
2022
Q3 | $1.71M | Buy |
8,526
+69
| +0.8% | +$14.9K | 0.01% | 1149 |
|
|
2022
Q2 | $1.91M | Buy |
8,457
+99
| +1% | +$24.2K | 0.02% | 1136 |
|
|
2022
Q1 | $2.48M | Sell |
8,358
-67
| -0.8% | -$20.7K | 0.02% | 1026 |
|
|
2021
Q4 | $2.68M | Sell |
8,425
-48
| -0.6% | -$18.6K | 0.02% | 959 |
|
|
2021
Q3 | $3.56M | Sell |
8,473
-2,511
| -23% | -$1.04M | 0.02% | 897 |
|
|
2021
Q2 | $4.62M | Sell |
10,984
-46,934
| -81% | -$15.7M | 0.03% | 762 |
|
|
2021
Q1 | $19.4M | Buy |
57,918
+5,177
| +10% | +$1.44M | 0.12% | 144 |
|
|
2020
Q4 | $14.8M | Buy |
52,741
+12,856
| +32% | +$3.06M | 0.09% | 199 |
|
|
2020
Q3 | $9.29M | Buy |
39,885
+1,468
| +4% | +$305K | 0.07% | 297 |
|
|
2020
Q2 | $7.61M | Buy |
38,417
+3,010
| +9% | +$480K | 0.06% | 338 |
|
|
2020
Q1 | $4.85M | Sell |
35,407
-828
| -2% | -$124K | 0.04% | 438 |
|
|
2019
Q4 | $5.69M | Buy |
36,235
+132
| +0.4% | +$18.3K | 0.04% | 466 |
|
|
2019
Q3 | $4.61M | Buy |
36,103
+1,156
| +3% | +$155K | 0.04% | 566 |
|
|
2019
Q2 | $4.73M | Sell |
34,947
-4,178
| -11% | -$567K | 0.04% | 539 |
|
|
2019
Q1 | $5.68M | Sell |
39,125
-704
| -2% | -$92.5K | 0.05% | 450 |
|
|
2018
Q4 | $4.75M | Buy |
39,829
+8,919
| +29% | +$1.12M | 0.04% | 521 |
|
|
2018
Q3 | $3.76M | Sell |
30,910
-5,628
| -15% | -$695K | 0.03% | 693 |
|
|
2018
Q2 | $4.38M | Sell |
36,538
-859
| -2% | -$92.9K | 0.03% | 723 |
|
|
2018
Q1 | $3.96M | Sell |
37,397
-116
| -0.3% | -$12.5K | 0.03% | 781 |
|
|
2017
Q4 | $3.96M | Buy |
37,513
+101
| +0.3% | +$11K | 0.03% | 829 |
|
|
2017
Q3 | $4.31M | Buy |
37,412
+116
| +0.3% | +$11.9K | 0.03% | 696 |
|
|
2017
Q2 | $3.79M | Buy |
37,296
+452
| +1% | +$41.6K | 0.03% | 747 |
|
|
2017
Q1 | $3.3M | Buy |
36,844
+1,803
| +5% | +$153K | 0.03% | 857 |
|
|
2016
Q4 | $2.82M | Buy |
35,041
+2,005
| +6% | +$152K | 0.02% | 966 |
|
|
2016
Q3 | $2.75M | Buy |
33,036
+486
| +1% | +$40.7K | 0.02% | 850 |
|
|
2016
Q2 | $2.74M | Buy |
32,550
+1,012
| +3% | +$83.4K | 0.02% | 853 |
|
|
2016
Q1 | $2.54M | Sell |
31,538
-836
| -3% | -$61.9K | 0.02% | 862 |
|
|
2015
Q4 | $2.56M | Sell |
32,374
-45
| -0.1% | -$3.25K | 0.03% | 811 |
|
|
2015
Q3 | $2.06M | Sell |
32,419
-32,967
| -50% | -$2.37M | 0.02% | 989 |
|
|
2015
Q2 | $4.6M | Buy |
65,386
+32,628
| +100% | +$2.41M | 0.02% | 998 |
|
|
2015
Q1 | $2.6M | Sell |
32,758
-32,554
| -50% | -$2.4M | 0.02% | 915 |
|
|
2014
Q4 | $4.16M | Buy |
65,312
+31,737
| +95% | +$1.99M | 0.02% | 1035 |
|
|
2014
Q3 | $2.01M | Sell |
33,575
-669
| -2% | -$38.3K | 0.02% | 1055 |
|
|
2014
Q2 | $1.83M | Sell |
34,244
-3,035
| -8% | -$167K | 0.02% | 1145 |
|
|
2014
Q1 | $2.25M | Buy |
37,279
+285
| +0.8% | +$16.6K | 0.02% | 1062 |
|
|
2013
Q4 | $1.96M | Sell |
36,994
-1,744
| -5% | -$87.6K | 0.02% | 1131 |
|
|
2013
Q3 | $1.79M | Buy |
38,738
+954
| +3% | +$43.8K | 0.01% | 1212 |
|
|
2013
Q2 | $1.55M | Buy |
+37,784
| New | +$1.62M | 0.01% | 1112 |
|
Other funds holding CRL
AI
Comerica Bank's CRL Position: Q4 2025 in Review
Comerica Bank reduced its Charles River Laboratories (CRL) stake by 56% in Q4 2025, selling an estimated $1.42M and leaving 6,197 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1397.
Comerica Bank first reported a position in CRL in Q2 2013 and has held it in 50 quarters since. The position peaked at $19.4M in Q1 2021. 581 funds tracked by Wall St. Rank hold CRL as of Q4 2025.
- Comerica Bank held 6,197 shares of Charles River Laboratories worth $1.24M as of Q4 2025.
- Comerica Bank sold 7,829 Charles River Laboratories shares in Q4 2025, an estimated $1.42M.
- Charles River Laboratories made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1397 holding.
- Comerica Bank first reported a position in Charles River Laboratories in Q2 2013 and has held it in 50 quarters since.
- Comerica Bank's Charles River Laboratories position peaked at $19.4M in Q1 2021.
- 581 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.